The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies

The aim of the study was to present the fingerprint of different <i>Lepidium peruvianum</i> tuber extracts showing glucosinolates-containing substances possibly playing an important role in preventinting dementia and other memory disorders. Different phenotypes of <i>Lepidium peruv...

Full description

Bibliographic Details
Main Authors: Dominik Tarabasz, Paweł Szczeblewski, Tomasz Laskowski, Wojciech Płaziński, Ewa Baranowska-Wójcik, Dominik Szwajgier, Wirginia Kukula-Koch, Henry O. Meissner
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/9/4858
_version_ 1797504462330265600
author Dominik Tarabasz
Paweł Szczeblewski
Tomasz Laskowski
Wojciech Płaziński
Ewa Baranowska-Wójcik
Dominik Szwajgier
Wirginia Kukula-Koch
Henry O. Meissner
author_facet Dominik Tarabasz
Paweł Szczeblewski
Tomasz Laskowski
Wojciech Płaziński
Ewa Baranowska-Wójcik
Dominik Szwajgier
Wirginia Kukula-Koch
Henry O. Meissner
author_sort Dominik Tarabasz
collection DOAJ
description The aim of the study was to present the fingerprint of different <i>Lepidium peruvianum</i> tuber extracts showing glucosinolates-containing substances possibly playing an important role in preventinting dementia and other memory disorders. Different phenotypes of <i>Lepidium peruvianum</i> (Brassicaceae) tubers were analysed for their glucosinolate profile using a liquid chromatograph coupled with mass spectrometer (HPLC-ESI-QTOF-MS/MS platform). Qualitative analysis in 50% ethanolic extracts confirmed the presence of ten compounds: aliphatic, indolyl, and aromatic glucosinolates, with glucotropaeolin being the leading one, detected at levels between 0–1.57% depending on phenotype, size, processing, and collection site. The PCA analysis showed important variations in glucosinolate content between the samples and different ratios of the detected compounds. Applied in vitro activity tests confirmed inhibitory properties of extracts and single glucosinolates against acetylcholinesterase (AChE) (15.3–28.9% for the extracts and 55.95–57.60% for individual compounds) and butyrylcholinesterase (BuChE) (71.3–77.2% for the extracts and 36.2–39.9% for individual compounds). The molecular basis for the activity of glucosinolates was explained through molecular docking studies showing that the tested metabolites interacted with tryptophan and histidine residues of the enzymes, most likely blocking their active catalytic side. Based on the obtained results and described mechanism of action, it could be concluded that glucosinolates exhibit inhibitory properties against two cholinesterases present in the synaptic cleft, which indicates that selected phenotypes of <i>L. peruvianum</i> tubers cultivated under well-defined environmental and ecological conditions may present a valuable plant material to be considered for the development of therapeutic products with memory-stimulating properties.
first_indexed 2024-03-10T04:04:55Z
format Article
id doaj.art-01eb65aea163497da899d58cf918f4e2
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:04:55Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-01eb65aea163497da899d58cf918f4e22023-11-23T08:23:16ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01239485810.3390/ijms23094858The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro StudiesDominik Tarabasz0Paweł Szczeblewski1Tomasz Laskowski2Wojciech Płaziński3Ewa Baranowska-Wójcik4Dominik Szwajgier5Wirginia Kukula-Koch6Henry O. Meissner7Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, PolandDepartment of Pharmaceutical Technology and Biochemistry and BioTechMed Centre, Faculty of Chemistry, Gdańsk University of Technology, Gabriela Narutowicza Str. 11/12, 80-233 Gdańsk, PolandDepartment of Pharmaceutical Technology and Biochemistry and BioTechMed Centre, Faculty of Chemistry, Gdańsk University of Technology, Gabriela Narutowicza Str. 11/12, 80-233 Gdańsk, PolandJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Krakow, PolandDepartment of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, Skromna 8 Street, 20-704 Lublin, PolandDepartment of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, Skromna 8 Street, 20-704 Lublin, PolandDepartment of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, PolandTherapeutic Research, TTD International Pty Ltd., 39 Leopard Ave., Elanora, Gold Coast 4221, AustraliaThe aim of the study was to present the fingerprint of different <i>Lepidium peruvianum</i> tuber extracts showing glucosinolates-containing substances possibly playing an important role in preventinting dementia and other memory disorders. Different phenotypes of <i>Lepidium peruvianum</i> (Brassicaceae) tubers were analysed for their glucosinolate profile using a liquid chromatograph coupled with mass spectrometer (HPLC-ESI-QTOF-MS/MS platform). Qualitative analysis in 50% ethanolic extracts confirmed the presence of ten compounds: aliphatic, indolyl, and aromatic glucosinolates, with glucotropaeolin being the leading one, detected at levels between 0–1.57% depending on phenotype, size, processing, and collection site. The PCA analysis showed important variations in glucosinolate content between the samples and different ratios of the detected compounds. Applied in vitro activity tests confirmed inhibitory properties of extracts and single glucosinolates against acetylcholinesterase (AChE) (15.3–28.9% for the extracts and 55.95–57.60% for individual compounds) and butyrylcholinesterase (BuChE) (71.3–77.2% for the extracts and 36.2–39.9% for individual compounds). The molecular basis for the activity of glucosinolates was explained through molecular docking studies showing that the tested metabolites interacted with tryptophan and histidine residues of the enzymes, most likely blocking their active catalytic side. Based on the obtained results and described mechanism of action, it could be concluded that glucosinolates exhibit inhibitory properties against two cholinesterases present in the synaptic cleft, which indicates that selected phenotypes of <i>L. peruvianum</i> tubers cultivated under well-defined environmental and ecological conditions may present a valuable plant material to be considered for the development of therapeutic products with memory-stimulating properties.https://www.mdpi.com/1422-0067/23/9/4858maca tubersPCAmodellingHPLC-MSAChE and BuChE inhibition
spellingShingle Dominik Tarabasz
Paweł Szczeblewski
Tomasz Laskowski
Wojciech Płaziński
Ewa Baranowska-Wójcik
Dominik Szwajgier
Wirginia Kukula-Koch
Henry O. Meissner
The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies
International Journal of Molecular Sciences
maca tubers
PCA
modelling
HPLC-MS
AChE and BuChE inhibition
title The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies
title_full The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies
title_fullStr The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies
title_full_unstemmed The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies
title_short The Distribution of Glucosinolates in Different Phenotypes of <i>Lepidium peruvianum</i> and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies
title_sort distribution of glucosinolates in different phenotypes of i lepidium peruvianum i and their role as acetyl and butyrylcholinesterase inhibitors in silico and in vitro studies
topic maca tubers
PCA
modelling
HPLC-MS
AChE and BuChE inhibition
url https://www.mdpi.com/1422-0067/23/9/4858
work_keys_str_mv AT dominiktarabasz thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT pawełszczeblewski thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT tomaszlaskowski thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT wojciechpłazinski thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT ewabaranowskawojcik thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT dominikszwajgier thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT wirginiakukulakoch thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT henryomeissner thedistributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT dominiktarabasz distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT pawełszczeblewski distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT tomaszlaskowski distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT wojciechpłazinski distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT ewabaranowskawojcik distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT dominikszwajgier distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT wirginiakukulakoch distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies
AT henryomeissner distributionofglucosinolatesindifferentphenotypesofilepidiumperuvianumiandtheirroleasacetylandbutyrylcholinesteraseinhibitorsinsilicoandinvitrostudies